8-K current report · filed Jun 10, 2026

Biogen (BIIB) 8-K Current Report: June 10, 2026

Short answer

Biogen (BIIB) filed an 8-K current report with the SEC on June 10, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). All ten director nominees elected to one-year terms through the 2027 annual meeting.

Biogen 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.07 · Submission of Matters to a Vote of Security Holders

  • All ten director nominees elected to one-year terms through the 2027 annual meeting
  • Board support varied materially, with Eric K. Rowinsky receiving 93,569,685 votes for and 28,216,589 against
  • Stockholders ratified PwC as independent auditor for fiscal 2026, with 124,551,887 votes for
  • Advisory executive-compensation proposal approved, with 114,184,816 votes for and 7,454,737 against

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Biogen 8-K filings

Get the next BIIB 8-K as it lands

Follow BIIB for push alerts, or ask the research agent what this filing means.